Back

β-Blockers for ED Presentations with Recent Cocaine Use: A Systematic Review

Paterson, T.; Katraj, S. V. K.; Van Wyk, A.; Pooranachandran, V.

2026-06-05 pharmacology and toxicology
10.64898/2026.06.02.729530 bioRxiv
Show abstract

BackgroundCocaine produces cardiovascular toxicity through intense sympathetic stimulation and direct myocardial injury, generating presentations ranging from hypertension and tachycardia to coronary vasospasm, arrhythmia, and myocardial depression. {beta}-blockers are foundational therapies in acute coronary syndromes, yet their use after cocaine exposure remains controversial due to concerns about unopposed -adrenergic stimulation. MethodsA systematic review was conducted in accordance with PRISMA guidelines. PubMed and Google Scholar (2000-2026) were searched for observational studies of adults ([≥]18 years) presenting to acute care with recent cocaine use that compared outcomes between {beta}-blocker recipients and non-recipients. Eligible studies reported in-hospital mortality, myocardial infarction/troponin rise, clinically significant arrhythmia, or haemodynamic instability. Risk of bias was assessed using the Newcastle-Ottawa Scale, and certainty of evidence using GRADE. ResultsFour retrospective ED cohorts (n = 1,140) met inclusion criteria; 503 patients received at least one {beta}-blocker dose. Across studies, {beta}-blocker use was not associated with increased in-hospital mortality or malignant arrhythmias. Myocardial infarction was heterogeneous and sensitive to definition and timing. Haemodynamic data showed no hypertensive surge and modest systolic blood pressure reductions. Risk of bias was moderate, and certainty of evidence very low to low. ConclusionsIn typical ED presentations of recent cocaine use, {beta}-blocker administration does not appear to increase mortality, myocardial infarction, or malignant arrhythmias, and available haemodynamic data do not support a reproducible unopposed- response. However, mechanistic and preclinical evidence suggests potential harm in severe intoxication or myocardial depression. A selective, phenotype-guided approach is warranted, and prospective mechanistic studies are needed. Key PointsO_LIBeta-blockers did not increase deaths, heart attacks, or dangerous heart rhythms in adults who came to the emergency department after recent cocaine use. C_LIO_LIBlood pressure generally decreased after beta-blocker treatment, and no consistent "unopposed alpha" reaction was seen in typical presentations. C_LIO_LICaution is still needed in severe intoxication or cases with heart muscle weakness, but for most emergency presentations, beta-blockers appear safe when used appropriately. C_LI

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 17%
10.8%
2
British Journal of Pharmacology
40 papers in training set
Top 0.1%
7.4%
3
Psychopharmacology
69 papers in training set
Top 0.2%
6.9%
4
Frontiers in Pharmacology
111 papers in training set
Top 0.3%
6.4%
5
The Journal of Infectious Diseases
202 papers in training set
Top 0.6%
5.3%
6
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.1%
4.1%
7
The Journal of Pharmacology and Experimental Therapeutics
18 papers in training set
Top 0.1%
4.1%
8
Pharmacoepidemiology and Drug Safety
18 papers in training set
Top 0.1%
3.3%
9
Circulation
74 papers in training set
Top 0.9%
3.3%
50% of probability mass above
10
Drug and Alcohol Dependence
41 papers in training set
Top 0.3%
2.5%
11
Journal of Clinical Medicine
97 papers in training set
Top 2%
2.2%
12
International Journal of Neuropsychopharmacology
14 papers in training set
Top 0.1%
1.9%
13
Circulation Research
47 papers in training set
Top 0.7%
1.8%
14
Neuropsychopharmacology
153 papers in training set
Top 2%
1.7%
15
Journal of Psychopharmacology
17 papers in training set
Top 0.2%
1.7%
16
Journal of the American Heart Association
140 papers in training set
Top 3%
1.5%
17
Clinical and Translational Science
22 papers in training set
Top 0.4%
1.1%
18
Pharmacology Research & Perspectives
11 papers in training set
Top 0.2%
1.1%
19
Pilot and Feasibility Studies
14 papers in training set
Top 0.5%
1.1%
20
Parkinsonism & Related Disorders
25 papers in training set
Top 0.4%
1.1%
21
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.2%
1.1%
22
Scientific Reports
3612 papers in training set
Top 68%
1.1%
23
Translational Psychiatry
260 papers in training set
Top 4%
1.0%
24
eClinicalMedicine
77 papers in training set
Top 2%
1.0%
25
Journal of Affective Disorders
92 papers in training set
Top 2%
0.9%
26
JAMA Psychiatry
15 papers in training set
Top 0.5%
0.9%
27
BMC Medicine
176 papers in training set
Top 5%
0.9%
28
American Journal of Physiology-Heart and Circulatory Physiology
36 papers in training set
Top 1%
0.9%
29
Neuropharmacology
68 papers in training set
Top 0.8%
0.9%
30
Computational and Structural Biotechnology Journal
242 papers in training set
Top 6%
0.9%